The PI3K inhibitor LY294002 and the mTOR inhibitor rapamycin sensitize melanoma cells to cisplatin and temozolomide
Gespeichert in:
| Veröffentlicht in: | Melanoma research 2006-09, Vol.16 (Supplement 1), p.S94 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | Supplement 1 |
| container_start_page | S94 |
| container_title | Melanoma research |
| container_volume | 16 |
| creator | Lasithiotakis, K. Sinnberg, T. Schittek, B. Garbe, C. Kulms, D. Maczey, E. Meier, F. |
| description | |
| doi_str_mv | 10.1097/00008390-200609001-00172 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00008390_200609001_00172</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1097_00008390_200609001_00172</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_1097_00008390_200609001_001723</originalsourceid><addsrcrecordid>eNqlj81KAzEQx3OoYLW-w7zA6mRT2825KIqCInvpKaTblI7kY8nk0j69aVHx7sAwMP8P-AkBEm8l6uUd1umUxqZFXKBGlE3dZTsRU9QLbDqt5KW4Yv48vdW9mgru9w7en9ULUNzThkrK8Lpu9RyxBRu3UKoe-rePP3q2ow2HgSKwi0yFjtXivI0pWBic9wwlwUA8eluq61zjQjomnwJt3Uxc7Kxnd_N9r0X3-NCvnpohJ-bsdmbMFGw-GInmBGZ-wMwvmDmDqX9EvwD1nVli</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The PI3K inhibitor LY294002 and the mTOR inhibitor rapamycin sensitize melanoma cells to cisplatin and temozolomide</title><source>Journals@Ovid Ovid Autoload</source><creator>Lasithiotakis, K. ; Sinnberg, T. ; Schittek, B. ; Garbe, C. ; Kulms, D. ; Maczey, E. ; Meier, F.</creator><creatorcontrib>Lasithiotakis, K. ; Sinnberg, T. ; Schittek, B. ; Garbe, C. ; Kulms, D. ; Maczey, E. ; Meier, F.</creatorcontrib><identifier>ISSN: 0960-8931</identifier><identifier>DOI: 10.1097/00008390-200609001-00172</identifier><language>eng</language><ispartof>Melanoma research, 2006-09, Vol.16 (Supplement 1), p.S94</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids></links><search><creatorcontrib>Lasithiotakis, K.</creatorcontrib><creatorcontrib>Sinnberg, T.</creatorcontrib><creatorcontrib>Schittek, B.</creatorcontrib><creatorcontrib>Garbe, C.</creatorcontrib><creatorcontrib>Kulms, D.</creatorcontrib><creatorcontrib>Maczey, E.</creatorcontrib><creatorcontrib>Meier, F.</creatorcontrib><title>The PI3K inhibitor LY294002 and the mTOR inhibitor rapamycin sensitize melanoma cells to cisplatin and temozolomide</title><title>Melanoma research</title><issn>0960-8931</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqlj81KAzEQx3OoYLW-w7zA6mRT2825KIqCInvpKaTblI7kY8nk0j69aVHx7sAwMP8P-AkBEm8l6uUd1umUxqZFXKBGlE3dZTsRU9QLbDqt5KW4Yv48vdW9mgru9w7en9ULUNzThkrK8Lpu9RyxBRu3UKoe-rePP3q2ow2HgSKwi0yFjtXivI0pWBic9wwlwUA8eluq61zjQjomnwJt3Uxc7Kxnd_N9r0X3-NCvnpohJ-bsdmbMFGw-GInmBGZ-wMwvmDmDqX9EvwD1nVli</recordid><startdate>200609</startdate><enddate>200609</enddate><creator>Lasithiotakis, K.</creator><creator>Sinnberg, T.</creator><creator>Schittek, B.</creator><creator>Garbe, C.</creator><creator>Kulms, D.</creator><creator>Maczey, E.</creator><creator>Meier, F.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200609</creationdate><title>The PI3K inhibitor LY294002 and the mTOR inhibitor rapamycin sensitize melanoma cells to cisplatin and temozolomide</title><author>Lasithiotakis, K. ; Sinnberg, T. ; Schittek, B. ; Garbe, C. ; Kulms, D. ; Maczey, E. ; Meier, F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_1097_00008390_200609001_001723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lasithiotakis, K.</creatorcontrib><creatorcontrib>Sinnberg, T.</creatorcontrib><creatorcontrib>Schittek, B.</creatorcontrib><creatorcontrib>Garbe, C.</creatorcontrib><creatorcontrib>Kulms, D.</creatorcontrib><creatorcontrib>Maczey, E.</creatorcontrib><creatorcontrib>Meier, F.</creatorcontrib><collection>CrossRef</collection><jtitle>Melanoma research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lasithiotakis, K.</au><au>Sinnberg, T.</au><au>Schittek, B.</au><au>Garbe, C.</au><au>Kulms, D.</au><au>Maczey, E.</au><au>Meier, F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The PI3K inhibitor LY294002 and the mTOR inhibitor rapamycin sensitize melanoma cells to cisplatin and temozolomide</atitle><jtitle>Melanoma research</jtitle><date>2006-09</date><risdate>2006</risdate><volume>16</volume><issue>Supplement 1</issue><spage>S94</spage><pages>S94-</pages><issn>0960-8931</issn><doi>10.1097/00008390-200609001-00172</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0960-8931 |
| ispartof | Melanoma research, 2006-09, Vol.16 (Supplement 1), p.S94 |
| issn | 0960-8931 |
| language | eng |
| recordid | cdi_crossref_primary_10_1097_00008390_200609001_00172 |
| source | Journals@Ovid Ovid Autoload |
| title | The PI3K inhibitor LY294002 and the mTOR inhibitor rapamycin sensitize melanoma cells to cisplatin and temozolomide |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T09%3A09%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20PI3K%20inhibitor%20LY294002%20and%20the%20mTOR%20inhibitor%20rapamycin%20sensitize%20melanoma%20cells%20to%20cisplatin%20and%20temozolomide&rft.jtitle=Melanoma%20research&rft.au=Lasithiotakis,%20K.&rft.date=2006-09&rft.volume=16&rft.issue=Supplement%201&rft.spage=S94&rft.pages=S94-&rft.issn=0960-8931&rft_id=info:doi/10.1097/00008390-200609001-00172&rft_dat=%3Ccrossref%3E10_1097_00008390_200609001_00172%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |